Physician profile
Heather E Mcdonald
NPI 1003142886
$1,626.71
in general payments reported to CMS, 2019-2025
20 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.53 · 2020: $134 · 2021: $320 · 2022: $451 · 2023: $347 · 2024: $120 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $303.30 | 2022-2023 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.32 | 2020-2022 | |
| Novo Nordisk INC | $180.75 | 2022-2025 | |
| Amarin Pharma, INC. | $170.00 | 2021-2022 | |
| Abbott Laboratories | $117.36 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $110.30 | 2019-2023 | |
| Astellas Pharma US INC | $105.79 | 2023-2025 | Xtandi, Veozah |
| Bausch Health US, LLC | $67.41 | 2023 | Aplenzin, Wellbutrin |
| Ibsa Pharma INC. | $46.86 | 2022-2023 | Tirosint, Licart |
| Pfizer INC. | $44.53 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $37.21 | 2024-2025 | |
| Amgen INC. | $35.63 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.16 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.83 | 2022 | |
| Glaxosmithkline, LLC. | $23.58 | 2023 | Arexvy, Shingrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $21.35 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.50 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.72 | 2019 | |
| Tactile Systems Technology INC | $17.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.